Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Prenatal Drug Exposures and Neurodevelopmental Programming of Glucocorticoid Signaling.

Franks AL, Berry KJ, DeFranco DB.

J Neuroendocrinol. 2019 Aug 30:e12786. doi: 10.1111/jne.12786. [Epub ahead of print] Review.

PMID:
31469457
2.

E-cadherin is downregulated in benign prostatic hyperplasia and required for tight junction formation and permeability barrier in the prostatic epithelial cell monolayer.

Li F, Pascal LE, Stolz DB, Wang K, Zhou Y, Chen W, Xu Y, Chen Y, Dhir R, Parwani AV, Nelson JB, DeFranco DB, Yoshimura N, Balasubramani GK, Gingrich JR, Maranchie JK, Jacobs BL, Davies BJ, Hrebinko RL, Bigley JD, McBride D, Guo P, He D, Wang Z.

Prostate. 2019 Aug;79(11):1226-1237. doi: 10.1002/pros.23806. Epub 2019 Jun 18.

PMID:
31212363
3.

The role of prostaglandin and E series prostaglandin receptor type 4 receptors in the development of bladder overactivity in a rat model of chemically induced prostatic inflammation.

Mizoguchi S, Wolf-Johnson AS, Ni J, Mori K, Suzuki T, Takaoka E, Mimata H, DeFranco DB, Wang Z, Birder LA, Yoshimura N.

BJU Int. 2019 Jun 5. doi: 10.1111/bju.14845. [Epub ahead of print]

PMID:
31166645
4.

Long-lasting bladder overactivity and bladder afferent hyperexcitability in rats with chemically-induced prostatic inflammation.

Ni J, Mizoguchi S, Bernardi K, Suzuki T, Kurobe M, Takaoka E, Wang Z, DeFranco DB, Tyagi P, Gu B, Yoshimura N.

Prostate. 2019 Jun;79(8):872-879. doi: 10.1002/pros.23794. Epub 2019 Mar 22.

PMID:
30900300
5.

Bladder overactivity and afferent hyperexcitability induced by prostate-to-bladder cross-sensitization in rats with prostatic inflammation.

Funahashi Y, Takahashi R, Mizoguchi S, Suzuki T, Takaoka E, Ni J, Wang Z, DeFranco DB, de Groat WC, Tyagi P, Yoshimura N.

J Physiol. 2019 Apr;597(7):2063-2078. doi: 10.1113/JP277452. Epub 2019 Feb 12.

PMID:
30666643
6.

Chaperoning skin atrophy.

DeFranco DB.

Oncotarget. 2018 Nov 23;9(92):36407-36408. doi: 10.18632/oncotarget.26375. eCollection 2018 Nov 23. No abstract available.

7.

The Hypothalamic-Pituitary-Adrenal Axis and the Fetus.

Morsi A, DeFranco D, Witchel SF.

Horm Res Paediatr. 2018;89(5):380-387. doi: 10.1159/000488106. Epub 2018 Jun 6. Review.

PMID:
29874660
8.

Statins impact primary embryonic mouse neural stem cell survival, cell death, and fate through distinct mechanisms.

Carson RA, Rudine AC, Tally SJ, Franks AL, Frahm KA, Waldman JK, Silswal N, Burale S, Phan JV, Chandran UR, Monaghan AP, DeFranco DB.

PLoS One. 2018 May 8;13(5):e0196387. doi: 10.1371/journal.pone.0196387. eCollection 2018.

9.

Glucocorticoid Signaling in Health and Disease: Insights From Tissue-Specific GR Knockout Mice.

Whirledge S, DeFranco DB.

Endocrinology. 2018 Jan 1;159(1):46-64. doi: 10.1210/en.2017-00728. Review.

10.

Antenatal dexamethasone exposure differentially affects distinct cortical neural progenitor cells and triggers long-term changes in murine cerebral architecture and behavior.

Tsiarli MA, Rudine A, Kendall N, Pratt MO, Krall R, Thiels E, DeFranco DB, Monaghan AP.

Transl Psychiatry. 2017 Jun 13;7(6):e1153. doi: 10.1038/tp.2017.65.

11.

A comparison of the sexually dimorphic dexamethasone transcriptome in mouse cerebral cortical and hypothalamic embryonic neural stem cells.

Frahm KA, Waldman JK, Luthra S, Rudine AC, Monaghan-Nichols AP, Chandran UR, DeFranco DB.

Mol Cell Endocrinol. 2018 Aug 15;471:42-50. doi: 10.1016/j.mce.2017.05.026. Epub 2017 May 26.

12.

Effects of Estrogen Receptor β Stimulation in a Rat Model of Non-Bacterial Prostatic Inflammation.

Mizoguchi S, Mori K, Wang Z, Liu T, Funahashi Y, Sato F, DeFranco DB, Yoshimura N, Mimata H.

Prostate. 2017 May;77(7):803-811. doi: 10.1002/pros.23320. Epub 2017 Feb 9.

13.

Editorial: Reflections on the Impact of Molecular Endocrinology on a Scientific Career.

DeFranco DB.

Mol Endocrinol. 2016 Oct;30(10):1025-1026. No abstract available.

14.

Effects of antenatal glucocorticoids on the developing brain.

Carson R, Monaghan-Nichols AP, DeFranco DB, Rudine AC.

Steroids. 2016 Oct;114:25-32. doi: 10.1016/j.steroids.2016.05.012. Epub 2016 Jun 23. Review.

15.

Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-Reductase Inhibition in Prostate Epithelial Cells.

Liu TT, Grubisha MJ, Frahm KA, Wendell SG, Liu J, Ricke WA, Auchus RJ, DeFranco DB.

J Biol Chem. 2016 Jul 8;291(28):14747-60. doi: 10.1074/jbc.M115.711515. Epub 2016 May 13.

16.

Research Resource: The Dexamethasone Transcriptome in Hypothalamic Embryonic Neural Stem Cells.

Frahm KA, Peffer ME, Zhang JY, Luthra S, Chakka AB, Couger MB, Chandran UR, Monaghan AP, DeFranco DB.

Mol Endocrinol. 2016 Jan;30(1):144-54. doi: 10.1210/me.2015-1258. Epub 2015 Nov 25.

17.

Erratum: Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.

Leach DA, Need EF, Toivanen R, Trotta AP, Palethorpe HM, Tamblyn DJ, Kopsaftis T, England GM, Smith E, Drew PA, Pinnock CB, Lee P, Holst J, Risbridger GP, Chopra S, DeFranco DB, Taylor RA, Buchanan G.

Oncotarget. 2015 Nov 3;6(34):36923. doi: 10.18632/oncotarget.6263. No abstract available.

18.

Estrogens and Male Lower Urinary Tract Dysfunction.

Wynder JL, Nicholson TM, DeFranco DB, Ricke WA.

Curr Urol Rep. 2015 Sep;16(9):61. doi: 10.1007/s11934-015-0534-6. Review.

19.

Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.

Leach DA, Need EF, Toivanen R, Trotta AP, Palethorpe HM, Tamblyn DJ, Kopsaftis T, England GM, Smith E, Drew PA, Pinnock CB, Lee P, Holst J, Risbridger GP, Chopra S, DeFranco DB, Taylor RA, Buchanan G.

Oncotarget. 2015 Jun 30;6(18):16135-50. Erratum in: Oncotarget. 2015 Nov 3;6(34):36923. Palenthorpe, Helen M [Corrected to Palethorpe, Helen M].

20.

Noncoding RNAs that associate with YB-1 alter proliferation in prostate cancer cells.

Liu TT, Arango-Argoty G, Li Z, Lin Y, Kim SW, Dueck A, Ozsolak F, Monaghan AP, Meister G, DeFranco DB, John B.

RNA. 2015 Jun;21(6):1159-72. doi: 10.1261/rna.045559.114. Epub 2015 Apr 22.

21.

Minireview: the impact of antenatal therapeutic synthetic glucocorticoids on the developing fetal brain.

Peffer ME, Zhang JY, Umfrey L, Rudine AC, Monaghan AP, DeFranco DB.

Mol Endocrinol. 2015 May;29(5):658-66. doi: 10.1210/me.2015-1042. Epub 2015 Mar 12. Review.

22.

Influence of E. coli-induced prostatic inflammation on expression of androgen-responsive genes and transforming growth factor beta 1 cascade genes in rats.

Funahashi Y, Wang Z, O'Malley KJ, Tyagi P, DeFranco DB, Gingrich JR, Takahashi R, Majima T, Gotoh M, Yoshimura N.

Prostate. 2015 Mar 1;75(4):381-9. doi: 10.1002/pros.22924. Epub 2014 Nov 28.

23.

The importance of basic science and research training for the next generation of physicians and physician scientists.

DeFranco DB, Sowa G.

Mol Endocrinol. 2014 Dec;28(12):1919-21. doi: 10.1210/me.2014-1343. No abstract available.

24.

Transient muscarinic and glutamatergic stimulation of neural stem cells triggers acute and persistent changes in differentiation.

Samarasinghe RA, Kanuparthi PS, Timothy Greenamyre J, DeFranco DB, Di Maio R.

Neurobiol Dis. 2014 Oct;70:252-61. doi: 10.1016/j.nbd.2014.06.020. Epub 2014 Jul 6.

25.

Comparison of succinimidyl [(125)I]iodobenzoate with iodogen iodination methods to study pharmacokinetics and ADME of biotherapeutics.

Chen J, Wang M, Joyce A, DeFranco D, Kavosi M, Xu X, O'Hara DM.

Pharm Res. 2014 Oct;31(10):2810-21. doi: 10.1007/s11095-014-1378-3. Epub 2014 May 21.

PMID:
24844406
26.

VDR activity is differentially affected by Hic-5 in prostate cancer and stromal cells.

Solomon JD, Heitzer MD, Liu TT, Beumer JH, Parise RA, Normolle DP, Leach DA, Buchanan G, DeFranco DB.

Mol Cancer Res. 2014 Aug;12(8):1166-80. doi: 10.1158/1541-7786.MCR-13-0395. Epub 2014 May 13.

27.

Caveolin-1 regulates genomic action of the glucocorticoid receptor in neural stem cells.

Peffer ME, Chandran UR, Luthra S, Volonte D, Galbiati F, Garabedian MJ, Monaghan AP, DeFranco DB.

Mol Cell Biol. 2014 Jul;34(14):2611-23.

28.

Upregulation of androgen-responsive genes and transforming growth factor-β1 cascade genes in a rat model of non-bacterial prostatic inflammation.

Funahashi Y, O'Malley KJ, Kawamorita N, Tyagi P, DeFranco DB, Takahashi R, Gotoh M, Wang Z, Yoshimura N.

Prostate. 2014 Apr;74(4):337-45. doi: 10.1002/pros.22668. Epub 2013 Dec 17.

29.

Hic-5 influences genomic and non-genomic actions of the androgen receptor in prostate myofibroblasts.

Leach DA, Need EF, Trotta AP, Grubisha MJ, DeFranco DB, Buchanan G.

Mol Cell Endocrinol. 2014 Mar 25;384(1-2):185-99. doi: 10.1016/j.mce.2014.01.004. Epub 2014 Jan 17.

PMID:
24440747
30.

Editorial: molecular endocrinology articles in the spotlight for December 2013.

Defranco DB.

Mol Endocrinol. 2013 Dec;27(12):1983. doi: 10.1210/me.2013-1350. No abstract available. Erratum in: Mol Endocrinol. 2014 Feb;28(2):275.

31.

Editorial: Molecular endocrinology articles in the spotlight for November 2013.

DeFranco DB.

Mol Endocrinol. 2013 Nov;27(11):1795. doi: 10.1210/me.2013-1310. No abstract available.

32.

Molecular endocrinology articles in the spotlight for October 2013.

DeFranco DB.

Mol Endocrinol. 2013 Oct;27(10):1592. doi: 10.1210/me.2013-1269. No abstract available.

33.

Editorial: Molecular endocrinology articles in the Spotlight for September 2013.

DeFranco DB.

Mol Endocrinol. 2013 Sep;27(9):1389. doi: 10.1210/me.2013-1238. No abstract available.

34.

Editorial: Molecular Endocrinology special feature minireviews for August 2013: GPCRs in Endocrine physiology and pathophysiology.

Hunyady L, DeFranco DB.

Mol Endocrinol. 2013 Aug;27(8):1175-6. doi: 10.1210/me.2013-1198. No abstract available.

35.

Editorial: Molecular Endocrinology articles in the spotlight for July 2013.

DeFranco DB.

Mol Endocrinol. 2013 Jul;27(7):1019. doi: 10.1210/me.2013-1170. No abstract available.

36.

Differential subcellular localization of the glucocorticoid receptor in distinct neural stem and progenitor populations of the mouse telencephalon in vivo.

Tsiarli MA, Paula Monaghan A, Defranco DB.

Brain Res. 2013 Jul 26;1523:10-27. doi: 10.1016/j.brainres.2013.06.001. Epub 2013 Jun 7.

37.

Editorial: molecular endocrinology articles in the spotlight for June 2013.

Defranco DB.

Mol Endocrinol. 2013 Jun;27(6):863. doi: 10.1210/me.2013-1126. No abstract available.

38.

Editorial: Molecular Endocrinology articles in the spotlight for May 2013.

DeFranco DB.

Mol Endocrinol. 2013 May;27(5):707. doi: 10.1210/me.2013-1096. No abstract available.

39.

Reduced glucocorticoid receptor protein expression in children with critical illness.

Indyk JA, Candido-Vitto C, Wolf IM, Venkataraman S, Munoz R, Saladino RA, Witchel SF, Defranco DB.

Horm Res Paediatr. 2013;79:169-78. doi: 10.1159/000348290. Epub 2013 Mar 8.

PMID:
23548248
40.

Editorial: molecular endocrinology articles in the spotlight for April 2013.

DeFranco DB.

Mol Endocrinol. 2013 Apr;27(4):557. doi: 10.1210/me.2013-1064. No abstract available.

41.

Editorial: molecular endocrinology articles in the spotlight for March 2013.

Defranco DB.

Mol Endocrinol. 2013 Mar;27(3):383. doi: 10.1210/me.2013-1023. No abstract available.

42.

Local endocrine, paracrine and redox signaling networks impact estrogen and androgen crosstalk in the prostate cancer microenvironment.

Grubisha MJ, DeFranco DB.

Steroids. 2013 Jun;78(6):538-41. doi: 10.1016/j.steroids.2013.01.005. Epub 2013 Feb 1. Review.

43.

Editorial: molecular endocrinology articles in the spotlight for February 2013.

DeFranco DB.

Mol Endocrinol. 2013 Feb;27(2):191. doi: 10.1210/me.2012-1410. No abstract available.

44.

Editorial: Molecular Endocrinology articles in the spotlight for January 2013.

Defranco DB.

Mol Endocrinol. 2013 Jan;27(1):1. doi: 10.1210/me.2012-1388. No abstract available.

45.

Editorial: Molecular Endocrinology articles in the spotlight for November 2012.

DeFranco DB.

Mol Endocrinol. 2012 Nov;26(11):1797. doi: 10.1210/me.2012-1326. No abstract available.

46.

Editorial: molecular endocrinology articles in the spotlight for October 2012.

Defranco DB, Margolis R, McKenna N.

Mol Endocrinol. 2012 Oct;26(10):1645. No abstract available.

47.

Editorial: molecular endocrinology articles in the spotlight for September 2012.

DeFranco DB.

Mol Endocrinol. 2012 Sep;26(9):1481. doi: 10.1210/me.2012-1246. No abstract available.

48.

Altered transcription factor trafficking in oxidatively-stressed neuronal cells.

Patel VP, Defranco DB, Chu CT.

Biochim Biophys Acta. 2012 Nov;1822(11):1773-82. doi: 10.1016/j.bbadis.2012.08.002. Epub 2012 Aug 8.

49.

Editorial: Molecular Endocrinology articles in the spotlight for August 2012.

DeFranco DB.

Mol Endocrinol. 2012 Aug;26(8):1251. doi: 10.1210/me.2012-1209. No abstract available.

50.

Cooperativity and complementarity: synergies in non-classical and classical glucocorticoid signaling.

Samarasinghe RA, Witchell SF, DeFranco DB.

Cell Cycle. 2012 Aug 1;11(15):2819-27. doi: 10.4161/cc.21018. Epub 2012 Aug 1. Review.

Supplemental Content

Loading ...
Support Center